Catheter Precision Statistics
Total Valuation
VTAK has a market cap or net worth of $2.15 million. The enterprise value is $1.93 million.
Important Dates
The next estimated earnings date is Monday, August 18, 2025, before market open.
| Earnings Date | Aug 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTAK has 12.59 million shares outstanding. The number of shares has increased by 784.28% in one year.
| Current Share Class | 12.59M |
| Shares Outstanding | 12.59M |
| Shares Change (YoY) | +784.28% |
| Shares Change (QoQ) | +18.87% |
| Owned by Insiders (%) | 3.45% |
| Owned by Institutions (%) | 3.63% |
| Float | 11.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.61 |
| Forward PS | 0.42 |
| PB Ratio | 0.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.22.
| Current Ratio | 0.44 |
| Quick Ratio | 0.39 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.33 |
Financial Efficiency
Return on equity (ROE) is -184.52% and return on invested capital (ROIC) is -65.90%.
| Return on Equity (ROE) | -184.52% |
| Return on Assets (ROA) | -29.44% |
| Return on Invested Capital (ROIC) | -65.90% |
| Return on Capital Employed (ROCE) | -58.33% |
| Revenue Per Employee | $27,273 |
| Profits Per Employee | -$1.09M |
| Employee Count | 22 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, VTAK has paid $1.47 million in taxes.
| Income Tax | 1.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.50% in the last 52 weeks. The beta is -0.28, so VTAK's price volatility has been lower than the market average.
| Beta (5Y) | -0.28 |
| 52-Week Price Change | -88.50% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.34 |
| Relative Strength Index (RSI) | 39.00 |
| Average Volume (20 Days) | 2,131,939 |
Short Selling Information
The latest short interest is 376,525, so 2.99% of the outstanding shares have been sold short.
| Short Interest | 376,525 |
| Short Previous Month | 444,845 |
| Short % of Shares Out | 2.99% |
| Short % of Float | 3.37% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, VTAK had revenue of $600,000 and -$24.06 million in losses. Loss per share was -$2.66.
| Revenue | 600,000 |
| Gross Profit | 554,000 |
| Operating Income | -12.20M |
| Pretax Income | -6.85M |
| Net Income | -24.06M |
| EBITDA | -10.08M |
| EBIT | -12.20M |
| Loss Per Share | -$2.66 |
Full Income StatementBalance Sheet
The company has $1.71 million in cash and $1.47 million in debt, giving a net cash position of $241,000 or $0.02 per share.
| Cash & Cash Equivalents | 1.71M |
| Total Debt | 1.47M |
| Net Cash | 241,000 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 6.55M |
| Book Value Per Share | 0.36 |
| Working Capital | -2.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.23 million and capital expenditures -$17,000, giving a free cash flow of -$9.72 million.
| Operating Cash Flow | -10.23M |
| Capital Expenditures | -17,000 |
| Free Cash Flow | -9.72M |
| FCF Per Share | -$0.77 |
Full Cash Flow StatementMargins
| Gross Margin | 92.33% |
| Operating Margin | -2,034.00% |
| Pretax Margin | -2,964.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |